Meridian Bioscience’s Campylobacter Assay Receives FDA Clearance
Meridian Bioscience says its Curian Campy assay—an immunoassay for the detection of a Campylobacter-specific antigen—received FDA clearance.
Read MorePosted by Andy Lundin | Jan 6, 2022 | Gastrointestinal Infections, Rapid Assays |
Meridian Bioscience says its Curian Campy assay—an immunoassay for the detection of a Campylobacter-specific antigen—received FDA clearance.
Read MorePosted by Andy Lundin | Jan 6, 2022 | Prostate, Rapid Assays |
A portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer.
Read MorePosted by Andy Lundin | Jan 4, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The FINDER 1.5 testing platform has the speed of a rapid antigen test and accuracy of an RT-PCR lab test.
Read MorePosted by Andy Lundin | Dec 22, 2021 | Anatomic Pathology, Covid 19 |
As genomic surveillance of COVID-19 continues, the ability of countries to contribute through rapid whole genome sequencing has become more important.
Read MorePosted by Andy Lundin | Dec 22, 2021 | Covid 19, Immunoassay Reagents & test Kits |
Global medical technology company BD has completed the acquisition of privately held Scanwell Health, a provider in smartphone-enabled at-home medical tests.
Read More